Oncolytic herpes virus retargeted to HER-2

Cell Cycle. 2009 Sep 15;8(18):2859-60. doi: 10.4161/cc.8.18.9368. Epub 2009 Sep 26.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / therapeutic use
  • Herpesviridae
  • Humans
  • Mice
  • Oncolytic Virotherapy / methods*
  • Oncolytic Viruses
  • Receptor, ErbB-2 / immunology*
  • Xenograft Model Antitumor Assays

Substances

  • Antibodies, Monoclonal
  • ERBB2 protein, human
  • Receptor, ErbB-2